Cargando…
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846615/ https://www.ncbi.nlm.nih.gov/pubmed/35180408 http://dx.doi.org/10.1016/S2214-109X(21)00593-3 |
_version_ | 1784651880643690496 |
---|---|
author | Parker, Edward P K Desai, Shalini Marti, Melanie Nohynek, Hanna Kaslow, David C Kochhar, Sonali O'Brien, Katherine L Hombach, Joachim Wilder-Smith, Annelies |
author_facet | Parker, Edward P K Desai, Shalini Marti, Melanie Nohynek, Hanna Kaslow, David C Kochhar, Sonali O'Brien, Katherine L Hombach, Joachim Wilder-Smith, Annelies |
author_sort | Parker, Edward P K |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8846615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-88466152022-02-16 Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review Parker, Edward P K Desai, Shalini Marti, Melanie Nohynek, Hanna Kaslow, David C Kochhar, Sonali O'Brien, Katherine L Hombach, Joachim Wilder-Smith, Annelies Lancet Glob Health Correspondence Elsevier Ltd 2022-02-15 /pmc/articles/PMC8846615/ /pubmed/35180408 http://dx.doi.org/10.1016/S2214-109X(21)00593-3 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Correspondence Parker, Edward P K Desai, Shalini Marti, Melanie Nohynek, Hanna Kaslow, David C Kochhar, Sonali O'Brien, Katherine L Hombach, Joachim Wilder-Smith, Annelies Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title_full | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title_fullStr | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title_full_unstemmed | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title_short | Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review |
title_sort | response to additional covid-19 vaccine doses in people who are immunocompromised: a rapid review |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846615/ https://www.ncbi.nlm.nih.gov/pubmed/35180408 http://dx.doi.org/10.1016/S2214-109X(21)00593-3 |
work_keys_str_mv | AT parkeredwardpk responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT desaishalini responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT martimelanie responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT nohynekhanna responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT kaslowdavidc responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT kochharsonali responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT obrienkatherinel responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT hombachjoachim responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview AT wildersmithannelies responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview |